CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


ClofazimineWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug1222 Interferon beta-1b Wiki 1.00
drug2434 TRV027 Wiki 1.00
drug3003 sodium chloride 0.9% Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D020141 Hemostatic Disorders NIH 0.30
D001778 Blood Coagulation Disorders NIH 0.30

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0001928 Abnormality of coagulation HPO 0.30

There is one clinical trial.

Clinical Trials


1 An Open-label Randomised Controlled Trial on Dual Therapy With Interferon Beta-1b and Clofazimine Combination, as Treatment for COVID-19 Infection

To conduct an open-label randomized controlled trial on a short course of interferon β-1b and clofazimine combination treatment for patients hospitalized for COVID-19 infection. To assess its safety and clinical efficacy.

NCT04465695 COVID-19 Drug: Interferon beta-1b Drug: Clofazimine

Primary Outcomes

Description: Time to complete alleviation of symptoms as defined by NEWS of 0 maintained for 24 hours

Measure: Clinical alleviation of symptoms

Time: 7 days

Secondary Outcomes

Description: Length of hospitalisation

Measure: Hospitalisation

Time: 14 days

Description: Time to negative nasopharyngeal swab, throat saliva and sputum viral load by RT-PCR

Measure: Time to negative viral load

Time: 7 days

Description: Cytokine/ chemokine changes

Measure: Inflammatory changes

Time: 7 days

Description: One month mortality rate

Measure: Mortality

Time: 30 days

Description: Adverse events during and shortly after treatment

Measure: Adverse events

Time: 30 days


No related HPO nodes (Using clinical trials)